COM:ATYRPHARMA
aTyr Pharma
- Stock
Last Close
1.85
04/06 20:00
Market Cap
131.12M
Beta: -
Volume Today
267.89K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -1.48M - | -40.48M 2,644.47% | ||||||||||
average payables | 1.24M - | 2.65M 113.22% | 3.24M 22.11% | 2.44M 24.64% | 1.66M 32.08% | 943.50K 43.09% | 1.14M 20.72% | 1.23M 8.08% | 2.07M 68.03% | 9.10M 339.79% | ||
average receivables | 1.02M - | 1.24M 21.33% | 6.11M 393.53% | 7.11M 16.39% | ||||||||
book value per share | -95.20 - | 6.85 107.19% | 101.70 1,384.80% | 37.13 63.49% | 34.82 6.21% | 15.71 54.88% | 6.27 60.11% | 3.44 45.15% | 5.72 66.40% | 2.51 56.14% | 1.69 32.72% | |
capex per share | -0.90 - | -0.35 61.34% | -0.59 69.60% | -0.35 39.56% | -0.71 100.47% | -0.28 61.00% | -0.02 91.51% | -0.02 6.33% | -0.01 54.37% | -0.06 473.84% | -0.08 36.17% | |
capex to depreciation | -0.90 - | -0.30 66.70% | -0.76 154.39% | -0.67 12.75% | -1.84 176.02% | -0.80 56.73% | -0.06 92.74% | -0.16 175.89% | -0.15 7.72% | -0.97 557.53% | -1.54 58.84% | |
capex to operating cash flow | 0.04 - | 0.01 70.67% | 0.02 65.40% | 0.01 37.10% | 0.03 172.85% | 0.02 38.25% | 0.00 79.36% | 0.01 234.44% | 0.01 56.03% | 0.04 574.90% | 0.13 223.85% | |
capex to revenue | -0.19 - | -0.02 89.68% | -0.16 - | -11.94 7,457.23% | ||||||||
cash per share | 50.67 - | 22.03 56.52% | 84.45 283.27% | 42.65 49.49% | 46.13 8.16% | 23.13 49.86% | 9.28 59.87% | 3.46 62.73% | 5.66 63.48% | 2.33 58.85% | 1.90 18.53% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | 71.18 - | 413.81 - | 2.52K 508.68% | |||||||||
debt to assets | 0.17 - | 0.50 187.60% | 0.04 92.03% | 0.12 198.68% | 0.22 86.44% | 0.30 37.63% | 0.32 6.67% | 0.06 82.16% | 0.01 79.37% | 0.12 909.60% | 0.13 3.90% | |
debt to equity | -0.10 - | 2.09 2,174.20% | 0.04 97.86% | 0.15 239.78% | 0.31 102.24% | 0.48 55.11% | 0.56 17.12% | 0.07 87.25% | 0.01 82.24% | 0.16 1,181.35% | 0.17 3.12% | |
dividend yield | 0.00 - | 0.00 61.64% | 0.00 69.72% | |||||||||
earnings yield | -0.13 - | -0.16 21.66% | -0.31 90.56% | -1.14 268.78% | -0.53 53.07% | -2.32 335.44% | -1.59 31.56% | -0.42 73.52% | -0.23 45.88% | -0.71 212.34% | -0.67 6.29% | |
enterprise value | 121.02M - | 146.97M 21.44% | 107.81M 26.65% | 22.06M 79.53% | 89.05M 303.59% | 7.93M 91.09% | 7.78M 1.97% | 20.83M 167.83% | 141.58M 579.71% | 63.79M 54.94% | 68.14M 6.81% | |
enterprise value over ebitda | -6.44 - | -6.46 0.31% | -2.26 64.94% | -0.38 83.17% | -1.89 395.76% | -0.24 87.20% | -0.34 40.02% | -1.31 286.79% | -4.16 217.94% | -1.37 66.97% | -1.24 9.75% | |
ev to operating cash flow | -6.99 - | -6.44 7.89% | -2.93 54.50% | -0.42 85.75% | -2.10 403.60% | -0.26 87.85% | -0.39 52.15% | -1.36 250.31% | -4.28 214.45% | -1.52 64.42% | -2.05 34.67% | |
ev to sales | 18.43 - | 1.99 89.19% | 6.14 - | 193.02 3,042.58% | ||||||||
free cash flow per share | -24.95 - | -32.07 28.50% | -33.11 3.26% | -31.61 4.55% | -23.67 25.10% | -14.78 37.57% | -5.99 59.49% | -1.69 71.73% | -1.74 3.02% | -1.53 12.15% | -0.70 54.40% | |
free cash flow yield | -0.12 - | -0.15 28.50% | -0.24 57.04% | -1.05 336.40% | -0.48 53.99% | -2.13 340.81% | -1.44 32.58% | -0.44 69.62% | -0.23 46.49% | -0.70 199.64% | -0.50 29.18% | |
graham net net | -96.47 - | 0.19 100.20% | 71.52 37,460.74% | 32.17 55.01% | 32.52 1.09% | 14.22 56.29% | 4.76 66.50% | 2.84 40.46% | 5.34 88.19% | 1.72 67.69% | 0.64 62.70% | |
graham number | 244.09 - | 72.22 70.41% | 311.49 331.33% | 169.03 45.73% | 143.07 15.36% | 75.47 47.25% | 30.57 59.50% | 11.24 63.24% | 14.80 31.67% | 9.38 36.63% | 5.97 36.29% | |
income quality | 0.86 - | 0.94 8.37% | 0.77 18.17% | 0.91 19.12% | 0.88 3.82% | 0.90 2.41% | 0.84 6.42% | 0.94 11.94% | 0.98 3.87% | 0.92 5.66% | 0.66 28.64% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | 44.01 - | 28.31 35.68% | 123.36 335.74% | -891.38 822.60% | 27.38 - | |||||||
interest debt per share | 8.95 - | 13.13 46.60% | 4.20 67.97% | 5.68 35.03% | 10.69 88.39% | 7.48 30.02% | 3.50 53.29% | 0.24 93.01% | 0.07 70.45% | 0.35 379.38% | 0.28 18.66% | |
inventory turnover | ||||||||||||
invested capital | -0.10 - | 2.09 2,174.20% | 0.04 97.86% | 0.15 239.78% | 0.31 102.24% | 0.48 55.11% | 0.56 17.12% | 0.07 87.25% | 0.01 82.24% | 0.16 1,181.35% | 0.17 3.12% | |
market cap | 150.59M - | 150.59M 0% | 155.69M 3.39% | 50.91M 67.30% | 90.41M 77.57% | 14.87M 83.56% | 13.99M 5.87% | 35.54M 154.00% | 142.53M 301.03% | 62.24M 56.33% | 75.59M 21.44% | |
net current asset value | -68.85M - | 793K 101.15% | 110.72M 13,862.67% | 58.43M 47.23% | 60.01M 2.71% | 30.45M 49.26% | 16.76M 44.95% | 28.50M 70.03% | 107.32M 276.52% | 56.58M 47.27% | 74.09M 30.94% | |
net debt to ebitda | 1.57 - | 0.16 89.88% | 1.01 531.76% | 0.50 50.46% | 0.03 94.21% | 0.21 632.18% | 0.27 28.08% | 0.92 241.83% | 0.03 96.95% | -0.03 218.83% | 0.14 505.28% | |
net income per share | -27.82 - | -33.84 21.66% | -42.40 25.30% | -34.20 19.34% | -26.13 23.61% | -16.11 38.33% | -6.63 58.87% | -1.63 75.36% | -1.70 4.19% | -1.56 8.43% | -0.94 39.67% | |
operating cash flow per share | -24.06 - | -31.72 31.85% | -32.53 2.54% | -31.25 3.92% | -22.96 26.53% | -14.50 36.84% | -5.96 58.87% | -1.67 71.99% | -1.73 3.77% | -1.47 14.97% | -0.62 57.95% | |
payables turnover | ||||||||||||
receivables turnover | 5.13 - | 0.88 - | 0.14 83.57% | |||||||||
research and ddevelopement to revenue | 33.29 - | 1.65 95.03% | 4.12 - | 119.81 2,806.81% | ||||||||
return on tangible assets | -0.50 - | -1.18 134.48% | -0.37 68.64% | -0.72 94.21% | -0.54 24.91% | -0.65 21.29% | -0.61 6.09% | -0.39 37.14% | -0.28 27.25% | -0.46 64.51% | -0.42 9.65% | |
revenue per share | 0.13 - | 1.14 807.56% | 0.37 - | 0.01 98.20% | ||||||||
roe | 0.29 - | -4.94 1,791.06% | -0.42 91.56% | -0.92 120.93% | -0.75 18.55% | -1.03 36.69% | -1.06 3.11% | -0.48 55.08% | -0.30 37.38% | -0.62 108.79% | -0.56 10.33% | |
roic | 0.32 - | -1.60 592.76% | -0.39 75.69% | -0.80 105.73% | -0.55 30.89% | -0.63 13.57% | -0.60 4.26% | -0.41 32.20% | -0.29 28.34% | -0.48 64.35% | -0.46 5.24% | |
sales general and administrative to revenue | 22.16 - | 0.87 96.08% | 1.35 - | 36.77 2,631.15% | ||||||||
shareholders equity per share | -95.20 - | 6.85 107.19% | 101.70 1,384.80% | 37.13 63.49% | 34.82 6.21% | 15.71 54.88% | 6.27 60.11% | 3.44 45.15% | 5.72 66.40% | 2.51 56.14% | 1.69 32.72% | |
stock based compensation to revenue | 4.23 - | 0.14 96.68% | 0.21 - | 7.37 3,451.41% | ||||||||
tangible asset value | -66.08M - | 4.93M 107.46% | 115.05M 2,234.62% | 62.80M 45.41% | 64.25M 2.30% | 33.65M 47.62% | 21.03M 37.52% | 31.48M 49.74% | 109.13M 246.61% | 71.28M 34.68% | 90.66M 27.18% | |
tangible book value per share | -91.84 - | 6.85 107.46% | 101.70 1,384.80% | 37.13 63.49% | 34.82 6.21% | 15.71 54.88% | 6.27 60.11% | 3.44 45.15% | 5.72 66.40% | 2.51 56.14% | 1.69 32.58% | |
working capital | 31.81M - | 6.71M 78.89% | 112.50M 1,575.35% | 67.62M 39.89% | 74.73M 10.51% | 38.71M 48.20% | 19.00M 50.91% | 29.88M 57.25% | 107.71M 260.49% | 67.22M 37.59% | 87.67M 30.41% |
All numbers in USD (except ratios and percentages)